These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12622347)

  • 1. Variations in affect following amphetamine and placebo: markers of stimulant drug preference.
    Gabbay FH
    Exp Clin Psychopharmacol; 2003 Feb; 11(1):91-101. PubMed ID: 12622347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain potential indices of novelty processing are associated with preference for amphetamine.
    Gabbay FH; Duncan CC; McDonald CG
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):470-88. PubMed ID: 21186922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine.
    Sigmon SC; Griffiths RR
    Drug Alcohol Depend; 2011 Nov; 118(2-3):341-8. PubMed ID: 21600707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective responses predict d-amphetamine choice in healthy volunteers.
    Murray CH; Li J; Weafer J; de Wit H
    Pharmacol Biochem Behav; 2021 May; 204():173158. PubMed ID: 33675838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual differences in responses to ethanol and d-amphetamine: a within-subject study.
    Holdstock L; de Wit H
    Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of expectancy and the pharmacological effects of d-amphetamine: subjective effects and self-administration.
    Mitchell SH; Laurent CL; de Wit H
    Psychopharmacology (Berl); 1996 Jun; 125(4):371-8. PubMed ID: 8826542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual differences in the reinforcing and subjective effects of amphetamine and diazepam.
    de Wit H; Uhlenhuth EH; Johanson CE
    Drug Alcohol Depend; 1986 Feb; 16(4):341-60. PubMed ID: 3698813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.
    Kirkpatrick MG; Goldenson NI; Kapadia N; Kahler CW; de Wit H; Swift RM; McGeary JE; Sussman S; Leventhal AM
    Psychopharmacology (Berl); 2016 Jan; 233(1):89-97. PubMed ID: 26429791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects.
    Dolder PC; Strajhar P; Vizeli P; Odermatt A; Liechti ME
    Psychopharmacology (Berl); 2018 May; 235(5):1389-1402. PubMed ID: 29511807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personality and the subjective effects of acute amphetamine in healthy volunteers.
    White TL; Lott DC; de Wit H
    Neuropsychopharmacology; 2006 May; 31(5):1064-74. PubMed ID: 16237380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family history of alcoholism and response to amphetamine: sex differences in the effect of risk.
    Gabbay FH
    Alcohol Clin Exp Res; 2005 May; 29(5):773-80. PubMed ID: 15897722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed-amphetamine salts expectancies among college students: Is stimulant induced cognitive enhancement a placebo effect?
    Cropsey KL; Schiavon S; Hendricks PS; Froelich M; Lentowicz I; Fargason R
    Drug Alcohol Depend; 2017 Sep; 178():302-309. PubMed ID: 28686989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
    Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior.
    Wardle MC; Garner MJ; Munafò MR; de Wit H
    Psychopharmacology (Berl); 2012 Sep; 223(2):199-210. PubMed ID: 22526538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual differences in drug abuse vulnerability: d-amphetamine and sensation-seeking status.
    Kelly TH; Robbins G; Martin CA; Fillmore MT; Lane SD; Harrington NG; Rush CR
    Psychopharmacology (Berl); 2006 Nov; 189(1):17-25. PubMed ID: 16972106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of d-amphetamine upon psychosocial stress responses.
    Childs E; Bershad AK; de Wit H
    J Psychopharmacol; 2016 Jul; 30(7):608-15. PubMed ID: 27235381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies.
    Fillmore MT; Rush CR; Marczinski CA
    Drug Alcohol Depend; 2003 Aug; 71(2):143-52. PubMed ID: 12927652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the subjective effects of stimulants in casual users. A methodology and preliminary results.
    Cole JO; Pope HG; LaBrie R; Ionescu-Pioggia M
    Clin Pharmacol Ther; 1978 Aug; 24(2):243-52. PubMed ID: 28194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.
    Stoops WW; Vansickel AR; Lile JA; Rush CR
    Pharmacol Biochem Behav; 2007 May; 87(1):20-9. PubMed ID: 17490738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.